Serotonin reuptake inhibitor antidepressants, including selective serotonin reuptake
inhibitors (SSRIs; ie, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and …

The amygdala is a limbic brain region that plays a key role in emotional processing,
neuropsychiatric disorders, and the emotional‐affective dimension of pain. Preclinical and …

Neuropathic pain arises as a direct consequence of a lesion or disease affecting the
somatosensory system. 87 It can be peripheral in origin, as a result of nerve injury or …

Neuropathic pain (NeuP) arises due to injury of the somatosensory nervous system and is
both common and disabling, rendering an urgent need for non-addictive, effective new …

Background: This systematic review summarizes the impact of pharmacogenetics on the
effect and safety of non-steroidal anti-inflammatory drugs (NSAIDs) and antidepressants …

Cocaine abuse and addiction remain great challenges on the public health agendas in the
US and the world. Increasingly sophisticated perspectives on addiction to cocaine and other …

Neuropathic pain is pain that arises as a direct consequence of a lesion or diseases
affecting the somatosensory system. Treatments for neuropathic pain include …

Neuropathic pain (NP) is an increasingly common chronic pain state and a major health
burden, affecting approximately 7% to 10% of the general population. Emerging evidence …

For genetic research to contribute more fully to furthering our knowledge of neuropathic
pain, we require an agreed, valid, and feasible approach to phenoty**, to allow …

Neuroplasticity in the amygdala drives pain-related behaviors. The central nucleus (CeA)
serves major amygdala output functions and can generate emotional-affective behaviors …